Atara Biotherapeutics Inc (ATRA) support and resistance · rev $128.9M
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
This page maps Atara Biotherapeutics Inc (ATRA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
ATRA currently screens at market cap $87.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ATRA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ATRA quote page for the session range and the stock page for the full model.
Not investment advice.